{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T03:02:16Z","timestamp":1771556536093,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although treatment of acute myeloid leukemia (AML) contains neurotoxic agents, studies investigating neurocognitive outcomes in children with AML are sparse. We evaluated late cognitive effects in children treated with a high-dose cytarabine based regimen, focusing on general intellectual ability and specific neurocognitive domains.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We evaluated 12 survivors of childhood AML who were treated between 2006 and 2016 and completed the Wechsler Intelligence Scales. One-sample <jats:italic>t<\/jats:italic>-tests were used to compare full-scale intelligence quotient (FSIQ) and primary index scores to norms. The overall effect of index scores and subtests was examined with one-way ANOVA. Univariate analyses and multiple regression models examined demographic and clinical characteristics associated with FSIQ.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Participants who underwent the Wechsler Intelligence Scale for Children demonstrated impairment on working memory index and participants who underwent the Wechsler Adult Intelligence Scale showed low score in the subtests that reflect working memory, whereas they exhibited no statistical differences versus the population means for FSIQ. There were no significant differences in the overall effect of index scores and subtests. On univariate analysis, FSIQ were related to time since diagnosis and age at assessment, and both were significant predictors of FSIQ on multiple linear regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Survivors of childhood AML exhibited impairment of working memory, even if their FSIQ was within the normal range. Difficulties in specific cognitive domains are associated with reduced quality of life. It is important to identify survivors who are at risk and provide tailored interventions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-022-03369-0","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T08:02:47Z","timestamp":1653120167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Neurocognitive deficits in survivors of childhood acute myeloid leukemia"],"prefix":"10.1186","volume":"22","author":[{"given":"Satoko","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satomi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Dairoku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Takiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Takimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,21]]},"reference":[{"key":"3369_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/ped.12865","volume":"58","author":"T Taga","year":"2016","unstructured":"Taga T, Tomizawa D, Takahashi H, Adachi S. Acute myeloid leukemia in children: current status and future directions. Pediatr Int. 2016;58:71\u201380. https:\/\/doi.org\/10.1111\/ped.12865.","journal-title":"Pediatr Int"},{"key":"3369_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/bjh.12040","volume":"159","author":"JE Rubnitz","year":"2012","unstructured":"Rubnitz JE, Inaba H. Childhood acute myeloid leukaemia. Br J Haematol. 2012;159:259\u201376. https:\/\/doi.org\/10.1111\/bjh.12040.","journal-title":"Br J Haematol"},{"key":"3369_CR3","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1200\/JCO.2000.18.18.3273","volume":"18","author":"W Leung","year":"2000","unstructured":"Leung W, Hudson MM, Strickland DK, Phipps S, Srivastava DK, Ribeiro RC, Rubnitz JE, Sandlund JT, Kun LE, Bowman LC, Razzouk BI, Mathew P, Shearer P, Evans WE, Pui CH. Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol. 2000;18:3273\u20139. https:\/\/doi.org\/10.1200\/JCO.2000.18.18.3273.","journal-title":"J Clin Oncol"},{"key":"3369_CR4","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1200\/JCO.2017.77.0180","volume":"36","author":"W Landier","year":"2018","unstructured":"Landier W, Skinner R, Wallace WH, Hjorth L, Mulder RL, Wong FL, Yasui Y, Bhakta N, Constine LS, Bhatia S, Kremer LC, Hudson MM. Surveillance for late effects in childhood cancer survivors. J Clin Oncol. 2018;36:2216\u201322. https:\/\/doi.org\/10.1200\/JCO.2017.77.0180.","journal-title":"J Clin Oncol"},{"key":"3369_CR5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/jnci\/djq156","volume":"102","author":"NS Kadan-Lottick","year":"2010","unstructured":"Kadan-Lottick NS, Zeltzer LK, Liu Q, Yasui Y, Ellenberg L, Gioia G, Robison LL, Krull KR. Neurocognitive functioning in adult survivors of childhood non-central nervous system cancers. J Natl Cancer Inst. 2010;102:881\u201393. https:\/\/doi.org\/10.1093\/jnci\/djq156.","journal-title":"J Natl Cancer Inst"},{"key":"3369_CR6","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/1097-0142(197602)37:2+<1079::aid-cncr2820370815>3.0.co;2-d","volume":"37","author":"AT Meadows","year":"1976","unstructured":"Meadows AT, Evans AE. Effects of chemotherapy on the central nervous system. A study of parenteral methotrexate in long-term survivors of leukemia and lymphoma in childhood. Cancer. 1976;37:1079\u201385. https:\/\/doi.org\/10.1002\/1097-0142(197602)37:2+%3c1079::aid-cncr2820370815%3e3.0.co;2-d.","journal-title":"Cancer"},{"key":"3369_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2165\/00002018-199005010-00003","volume":"5","author":"J Stentoft","year":"1990","unstructured":"Stentoft J. The toxicity of cytarabine. Drug Saf. 1990;5:7\u201327. https:\/\/doi.org\/10.2165\/00002018-199005010-00003.","journal-title":"Drug Saf"},{"key":"3369_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/1097-0142(19870715)60:2<165::aid-cncr2820600207>3.0.co;2-g","volume":"60","author":"NJ Barrios","year":"1987","unstructured":"Barrios NJ, Tebbi CK, Freeman AI, Brecher ML. Toxicity of high dose Ara-C in children and adolescents. Cancer. 1987;60:165\u20139. https:\/\/doi.org\/10.1002\/1097-0142(19870715)60:2%3c165::aid-cncr2820600207%3e3.0.co;2-g.","journal-title":"Cancer"},{"key":"3369_CR9","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1200\/JCO.1987.5.6.927","volume":"5","author":"RH Herzig","year":"1987","unstructured":"Herzig RH, Hines JD, Herzig GP, Wolff SN, Cassileth PA, Lazarus HM, Adelstein DJ, Brown RA, Coccia PF, Strandjord S, et al. Cerebellar toxicity with high-dose cytosine arabinoside. J Clin Oncol. 1987;5:927\u201332. https:\/\/doi.org\/10.1200\/JCO.1987.5.6.927.","journal-title":"J Clin Oncol"},{"key":"3369_CR10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1200\/JCO.1986.4.4.571","volume":"4","author":"S Nand","year":"1986","unstructured":"Nand S, Messmore HL Jr, Patel R, Fisher SG, Fisher RI. Neurotoxicity associated with systemic high-dose cytosine arabinoside. J Clin Oncol. 1986;4:571\u20135. https:\/\/doi.org\/10.1200\/JCO.1986.4.4.571.","journal-title":"J Clin Oncol"},{"key":"3369_CR11","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1200\/JCO.2008.18.7948","volume":"27","author":"I Tsukimoto","year":"2009","unstructured":"Tsukimoto I, Tawa A, Horibe K, Tabuchi K, Kigasawa H, Tsuchida M, Yabe H, Nakayama H, Kudo K, Kobayashi R, Hamamoto K, Imaizumi M, Morimoto A, Tsuchiya S, Hanada R. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: The AML99 trial from the Japanese childhood AML cooperative study group. J Clin Oncol. 2009;27:4007\u201313. https:\/\/doi.org\/10.1200\/JCO.2008.18.7948.","journal-title":"J Clin Oncol"},{"key":"3369_CR12","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1038\/leu.2013.153","volume":"27","author":"D Tomizawa","year":"2013","unstructured":"Tomizawa D, Tawa A, Watanabe T, Saito AM, Kudo K, Taga T, Iwamoto S, Shimada A, Terui K, Moritake H, Kinoshita A, Takahashi H, Nakayama H, Koh K, Kigasawa H, Kosaka Y, Miyachi H, Horibe K, Nakahata T, Adachi S. Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children. Leukemia. 2013;27:2413\u20136. https:\/\/doi.org\/10.1038\/leu.2013.153.","journal-title":"Leukemia"},{"key":"3369_CR13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/jjco\/hyy061","volume":"48","author":"D Tomizawa","year":"2018","unstructured":"Tomizawa D, Tanaka S, Hasegawa D, Iwamoto S, Hiramatsu H, Kiyokawa N, Miyachi H, Horibe K, Saito AM, Taga T, Adachi S. Evaluation of high-dose cytarabine in induction therapy for children with de novo acute myeloid leukemia: a study protocol of the Japan children\u2019s cancer group multi-center seamless Phase II\u2013III randomized trial (JPLSG AML-12). Jpn J Clin Oncol. 2018;48:587\u201393. https:\/\/doi.org\/10.1093\/jjco\/hyy061.","journal-title":"Jpn J Clin Oncol"},{"key":"3369_CR14","volume-title":"Essentials of WAIS-IV Assessment","author":"O Elizabeth","year":"2012","unstructured":"Elizabeth O, Lichtenberger ASK. Essentials of WAIS-IV Assessment. 2nd ed. New Jersey: John Wiley & Sons Inc; 2012.","edition":"2"},{"key":"3369_CR15","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138. https:\/\/doi.org\/10.1038\/bmt.2012.244.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"3369_CR16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/jnci\/djaa102","volume":"113","author":"KJ Stefanski","year":"2021","unstructured":"Stefanski KJ, Anixt JS, Goodman P, Bowers K, Leisenring W, Scott Baker K, Burns K, Howell R, Davies S, Robison LL, Armstrong GT, Krull KR, Recklitis C. Long-term neurocognitive and psychosocial outcomes after acute myeloid leukemia: A childhood cancer survivor study report. J Natl Cancer Inst. 2021;113(4):481\u201395. https:\/\/doi.org\/10.1093\/jnci\/djaa102.","journal-title":"J Natl Cancer Inst"},{"key":"3369_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1467-9280.2006.01681.x","volume":"17","author":"NP Friedman","year":"2006","unstructured":"Friedman NP, Miyake A, Corley RP, Young SE, Defries JC, Hewitt JK. Not all executive functions are related to intelligence. Psychol Sci. 2006;17:172\u20139. https:\/\/doi.org\/10.1111\/j.1467-9280.2006.01681.x.","journal-title":"Psychol Sci"},{"key":"3369_CR18","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3758\/bf03193017","volume":"39","author":"JT Shelton","year":"2007","unstructured":"Shelton JT, Metzger RL, Elliott EM. Modified lag task as a measure of working memory. Behav Res Methods. 2007;39:482\u201393. https:\/\/doi.org\/10.3758\/bf03193017.","journal-title":"Behav Res Methods"},{"key":"3369_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/13803390903032529","volume":"32","author":"BD Hill","year":"2010","unstructured":"Hill BD, Elliott EM, Shelton JT, Pella RD, O\u2019Jile JR, Gouvier WD. Can we improve the clinical assessment of working memory? An evaluation of the Wechsler Adult Intelligence Scale-Third Edition using a working memory criterion construct. J Clin Exp Neuropsychol. 2010;32:315\u201323. https:\/\/doi.org\/10.1080\/13803390903032529.","journal-title":"J Clin Exp Neuropsychol"},{"key":"3369_CR20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1176\/jnp.16.3.367","volume":"16","author":"JD Schmahmann","year":"2004","unstructured":"Schmahmann JD. Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci. 2004;16:367\u201378. https:\/\/doi.org\/10.1176\/jnp.16.3.367.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"3369_CR21","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/MPH.0b013e31802d3e2d","volume":"28","author":"I Pellier","year":"2006","unstructured":"Pellier I, Leboucher B, Rachieru P, Ifrah N, Rialland X. Flushing out of cerebrospinal fluid as a therapy for acute cerebellar dysfunction caused by high dose of cytosine arabinoside: a case report. J Pediatr Hematol Oncol. 2006;28:837\u20139. https:\/\/doi.org\/10.1097\/MPH.0b013e31802d3e2d.","journal-title":"J Pediatr Hematol Oncol"},{"key":"3369_CR22","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1200\/jco.1999.17.9.2804","volume":"17","author":"P V\u00e9ra","year":"1999","unstructured":"V\u00e9ra P, Rohrlich P, Sti\u00e9venart JL, Elmaleh M, Duval M, Bonnin F, Bok B, Vilmer E. Contribution of single-photon emission computed tomography in the diagnosis and follow-up of CNS toxicity of a cytarabine-containing regimen in pediatric leukemia. J Clin Oncol. 1999;17:2804\u201310. https:\/\/doi.org\/10.1200\/jco.1999.17.9.2804.","journal-title":"J Clin Oncol"},{"key":"3369_CR23","doi-asserted-by":"publisher","unstructured":"Iyer NS, Balsamo LM, Bracken MB, Kadan-Lottick NS (2015) Chemotherapy-only treatment effects on long-term neurocognitive functioning in childhood ALL survivors: A review and meta-analysis. Blood. 16;126(3):346\u2013353. https:\/\/doi.org\/10.1182\/blood-2015-02-627414.","DOI":"10.1182\/blood-2015-02-627414"},{"key":"3369_CR24","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","volume":"360","author":"CH Pui","year":"2009","unstructured":"Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S, Cheng C, Howard SC, Simmons V, Bayles A, Metzger ML, Boyett JM, Leung W, Handgretinger R, Downing JR, Evans WE, Relling MV. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360:2730\u201341.","journal-title":"N Engl J Med"},{"key":"3369_CR25","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1200\/JCO.2016.71.7587","volume":"35","author":"KK Hardy","year":"2017","unstructured":"Hardy KK, Embry L, Kairalla JA, Helian S, Devidas M, Armstrong D, Hunger S, Carroll WL, Larsen E, Raetz EA, Loh ML, Yang W, Relling MV, Noll RB, Winick N. Neurocognitive functioning of children treated for high-risk B-acute lymphoblastic leukemia randomly assigned to different methotrexate and corticosteroid treatment strategies: a report from the children\u2019s oncology group. J Clin Oncol. 2017;35:2700\u20137. https:\/\/doi.org\/10.1200\/JCO.2016.71.7587.","journal-title":"J Clin Oncol"},{"key":"3369_CR26","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1200\/JCO.2015.62.2589","volume":"34","author":"TM Brinkman","year":"2016","unstructured":"Brinkman TM, Krasin MJ, Liu W, Armstrong GT, Ojha RP, Sadighi ZS, Gupta P, Kimberg C, Srivastava D, Merchant TE, Gajjar A, Robison LL, Hudson MM, Krull KR. Long-term neurocognitive functioning and social attainment in adult survivors of pediatric CNS tumors: Results from the st jude lifetime cohort study. J Clin Oncol. 2016;34:1358\u201367. https:\/\/doi.org\/10.1200\/JCO.2015.62.2589.","journal-title":"J Clin Oncol"},{"key":"3369_CR27","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1038\/s41375-021-01134-3","volume":"35","author":"NS Bhatt","year":"2021","unstructured":"Bhatt NS, Baassiri MJ, Liu W, Bhakta N, Chemaitilly W, Ehrhardt MJ, Inaba H, Krull K, Ness KK, Rubnitz JE, Srivastava D, Robison LL, Hudson MM, Mulrooney DA. Late outcomes in survivors of childhood acute myeloid leukemia: a report from the St Jude lifetime cohort study. Leukemia. 2021;35:2258\u201373. https:\/\/doi.org\/10.1038\/s41375-021-01134-3.","journal-title":"Leukemia"},{"key":"3369_CR28","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3390\/cancers13050966","volume":"13","author":"R Di Francia","year":"2021","unstructured":"Di Francia R, Crisci S, De Monaco A, Cafiero C, Re A, Iaccarino G, De Filippi R, Frigeri F, Corazzelli G, Micera A, Pinto A. Response and toxicity to cytarabine therapy in leukemia and lymphoma: from dose puzzle to pharmacogenomic biomarkers. Cancers (Basel). 2021;13:966. https:\/\/doi.org\/10.3390\/cancers13050966.","journal-title":"Cancers (Basel)"},{"key":"3369_CR29","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1200\/JCO.2012.46.7944","volume":"31","author":"KR Krull","year":"2013","unstructured":"Krull KR, Bhojwani D, Conklin HM, Pei D, Cheng C, Reddick WE, Sandlund JT, Pui CH. Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol. 2013;31:2182\u20138. https:\/\/doi.org\/10.1200\/JCO.2012.46.7944.","journal-title":"J Clin Oncol"},{"key":"3369_CR30","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1200\/JCO.2017.76.4696","volume":"36","author":"KR Krull","year":"2018","unstructured":"Krull KR, Hardy KK, Kahalley LS, Schuitema I, Kesler SR. Neurocognitive outcomes and interventions in long-term survivors of childhood cancer. J Clin Oncol. 2018;36:2181\u20139. https:\/\/doi.org\/10.1200\/JCO.2017.76.4696.","journal-title":"J Clin Oncol"},{"key":"3369_CR31","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1136\/adc.2008.153809","volume":"95","author":"P Temming","year":"2010","unstructured":"Temming P, Jenney MEM. The neurodevelopmental sequelae of childhood leukaemia and its treatment. Arch Dis Child. 2010;95:936\u201340. https:\/\/doi.org\/10.1136\/adc.2008.153809.","journal-title":"Arch Dis Child"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03369-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-022-03369-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03369-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T08:05:14Z","timestamp":1653120314000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-022-03369-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,21]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3369"],"URL":"https:\/\/doi.org\/10.1186\/s12887-022-03369-0","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,21]]},"assertion":[{"value":"14 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of the Japanese Red Cross Narita Hospital approved this study (Approval Number: 526\u201301).Written informed consent for participation and medical record release was obtained from survivors over the age of 16 and proxies (for participants younger than 20\u00a0years). Assent was obtained from survivors where appropriate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"298"}}